Übersichtsarbeit
Ketamine for Major Depressive Disorder
Current Topics in Behavioral Neurosciences · 2023
DOI: 10.1007/7854_2023_453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Topics in Behavioral Neurosciences, 2023. Verfasst von Sara Costi. Beteiligte Einrichtung: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. sara.costi@psych.ox.ac.uk. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, Antidepressive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
KetamineMajor Depressive DisorderAntidepressive AgentsHumansDepressive Disorder, Treatment-ResistantReceptors, N-Methyl-D-AspartateAnimalsExcitatory Amino Acid Antagonists
Stichwörter der Autor:innen
EsketamineGlutamateKetamineMajor depressive disorderSuicideTreatment resistant depression
Substanzen
KetamineAntidepressive AgentsReceptors, N-Methyl-D-AspartateExcitatory Amino Acid Antagonists
Autor:innen und Institutionen
- Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. sara.costi@psych.ox.ac.uk.
- Oxford Health Foundation Trust, Warneford Hospital, Oxford, UK. sara.costi@psych.ox.ac.uk.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. sara.costi@psych.ox.ac.uk.
Zitieren
APA
Costi, S. (2023). Ketamine for Major Depressive Disorder. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2023_453
Vancouver
Costi S. Ketamine for Major Depressive Disorder. Current Topics in Behavioral Neurosciences. 2023. doi:10.1007/7854_2023_453
BibTeX
@article{Costi2023,
author = {Costi, Sara},
title = {Ketamine for Major Depressive Disorder},
journal = {Current Topics in Behavioral Neurosciences},
year = {2023},
doi = {10.1007/7854_2023_453}
}
EUVIMED